May 2004
American Surgeon;May2004, Vol. 70 Issue 5, p395
Academic Journal
Presents comments on the article "Congenital Diaphragmatic Hernia Repair on Extracorporeal Life Support: A Decade of Lessons Learned," by Mary T. Austin and colleagues. Results of a study of 30 patients with congenital diaphragmatic hernia who were repaired while on extracorporeal membrane oxygenation (ECMO); Potential complications from the disease; Reason for continuous repair of hernias while the patients are on ECMO; Selection process for the patients who will undergo veno-arterial bypass.


Related Articles

  • Congenital diaphragmatic hernia. Rais-Bahrami, Khodayar; Robbins, Sandra T. // Clinical Pediatrics;Sep1995, Vol. 34 Issue 9, p471 

    Compares the two-year outcome of a high-risk congenital diaphragmatic hernia (CDH) group (infants placed on extracorporeal membrane oxygenation (ECMO) presurgery) with a lower-risk group (those placed on ECMO after surgery). Higher frequency of reherniation in parch-repair infants compared with...

  • Nutrition support during extracorporeal membrane oxygenation (ECMO) in adults. Umezawa Makikado, Luis; Flordelís Lasierra, José; Pérez-Vela, José; Montejo González, Juan // Intensive Care Medicine;Dec2013, Vol. 39 Issue 12, p2240 

    A letter to the editor is presented in response to the article "Nutrition Support During ECMO in Adults: A Retrospective Audit" by S. Ferrie et al. that was published in 2013.

  • Risk of Need for Extracorporeal Membrane Oxygenation Support in Neonates with Congenital Diaphragmatic Hernia Treated with Inhaled Nitric Oxide. Sebald, Matthew; Friedlich, Philippe; Burns, Cartland; Stein, James; Noori, Shahab; Ramanathan, Rangasamy; Seri, Istvan // Journal of Perinatology;Mar2004, Vol. 24 Issue 3, p143 

    BACKGROUND:: Congenital diaphragmatic hernia (CDH) is often associated with severe pulmonary hypoplasia resulting in hypoxemic respiratory failure unresponsive to advanced medical management including the use of inhaled nitric oxide (iNO). For these patients, extracorporeal membrane oxygenation...

  • Heart Rate Variability as an Indicator of Outcome in Congenital Diaphragmatic Hernia With and Without ECMO Support. Verklan, M. Terese; Nikhil S. Padhye // Journal of Perinatology;Apr2004, Vol. 24 Issue 4, p247 

    OBJECTIVE:: To examine differences in the spectral power content in neonates diagnosed with congenital diaphragmatic hernia (CDH) who survive or succumb. STUDY DESIGN:: A case-series study design evaluated four neonates diagnosed with CDH, two of which were supported by extracorporeal membrane...

  • Rana mobilazacija bolesnika priključenih na potporu ekstrakorporalne membranske oksigenacije. Kraljević, Aleksandra; Skendrović, Ana; Javor, Dijana // Cardiologia Croatica;Sep/Oct2014, Vol. 9 Issue 9/10, p493 

    INTRODUCTION: In a significant number of patients, chronic heart failure even when administering optimal conservative therapy progresses to the stage of the circulatory shock. The usage of the extracorporeal membrane oxygenation (ECMO) devices may be used to temporarily manage such patients...

  • Extracorporeal Membrane Oxygenation Support in a Patient with Status Asthmaticus. Min Ho Ju; Jeong-Jun Park; Won Kyoung Jhang; Seong Jong Park; Hong Ju Shin // Korean Journal of Thoracic & Cardiovascular Surgery;2012, Vol. 45 Issue 3, p186 

    Status asthmaticus is a rare, fatal condition, especially in children. Sometimes respiratory support is insufficient with a mechanical ventilator or medical therapy for patients with status asthmaticus. In such situations, early extracorporeal membrane oxygenation application is a useful method...

  • Should Zelen pre-randomised consent designs be used in some neonatal trials? Allmark, Peter // Journal of Medical Ethics;Aug99, Vol. 25 Issue 4, p325 

    My aim is to suggest that there is a case for using a randomised consent design in some neonatal trials. As an example I use the trials of extracorporeal membrane oxygenation (ECMO) in neonates suffering pulmonary hypertension. In some trials the process of obtaining consent has the potential to...

  • Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated. Pappalardo, F.; Maj, G.; Scandroglio, A.; Sampietro, F.; Zangrillo, A.; Koster, A. // Perfusion;Mar2009, Vol. 24 Issue 2, p135 

    Heparin-induced thrombocytopenia (HIT) is a serious, antibody-mediated complication of heparin which significantly confers risks of thrombosis and devastating outcomes. Once diagnosed, it requires immediate cessation of heparin and therapy with an alternative anticoagulant. No data are available...

  • Pulmonary Alveolar Proteinosis in Extremis: The Case for Aggressive Whole Lung Lavage with Extracorporeal Membrane Oxygenation Support Sihoe, Alan D.L.; Ng, Vivian M.W.; Liu, Raymond W.T.; Cheng, Lik-Cheung // Heart, Lung & Circulation;Feb2008, Vol. 17 Issue 1, p69 

    Pulmonary alveolar proteinosis (PAP) is a rare disorder in which lipoproteinaceous material is deposited in the alveoli, compromising gaseous exchange. We report the case of a 29-year-old female patient presenting with the most extreme case of PAP yet reported. She successfully managed by...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics